Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.

about

Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.

Item

http://www.wikidata.org/entity/Q53076446

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clinical Trial of the Potassiu ...... Halted Due to Intolerability.

@en

Clinical Trial of the Potassiu ...... Halted Due to Intolerability.

@nl

type

Item

label

Clinical Trial of the Potassiu ...... Halted Due to Intolerability.

@en

Clinical Trial of the Potassiu ...... Halted Due to Intolerability.

@nl

prefLabel

Clinical Trial of the Potassiu ...... Halted Due to Intolerability.

@en

Clinical Trial of the Potassiu ...... Halted Due to Intolerability.

@nl

P1476

Clinical Trial of the Potassiu ...... Halted Due to Intolerability.

@en

P2093

Aaron Yazdian

http://www.w3.org/2001/XMLSchema#string

Allison C Nugent

http://www.w3.org/2001/XMLSchema#string

Elizabeth D Ballard

http://www.w3.org/2001/XMLSchema#string

Fritz A Henn

http://www.w3.org/2001/XMLSchema#string

Lawrence T Park

http://www.w3.org/2001/XMLSchema#string

Marc S Lener

http://www.w3.org/2001/XMLSchema#string

Minkyung Park

http://www.w3.org/2001/XMLSchema#string

Shiwen Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers

Astrocyte glutamate transport: review of properties, regulation, and physiological functions

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.

Activation of K(ATP) channels suppresses glucose production in humans.

P304

243-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JCP.0000000000000866

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29601316

http://www.w3.org/2001/XMLSchema#string

P932

5903962

http://www.w3.org/2001/XMLSchema#string